4.8 Article

Continuous Effector CD8+ T Cell Production in a Controlled Persistent Infection Is Sustained by a Proliferative Intermediate Population

期刊

IMMUNITY
卷 45, 期 1, 页码 159-171

出版社

CELL PRESS
DOI: 10.1016/j.immuni.2016.06.013

关键词

-

资金

  1. American National Institutes of Health [P01 AI065831, R01 AI065537, AI093132]
  2. American Heart Association
  3. California Institute for Regenerative Medicine
  4. Human Frontier Science Program
  5. UK's National Centre for Replacement, Refinement and Reduction of Animals in Research [NC/K001280/1]
  6. Leeds Fund for International Research Collaborations
  7. Biotechnology and Biological Sciences Research Council [BB/F003811/1, BB/G023395/1]
  8. Biotechnology and Biological Sciences Research Council [BB/G023395/1, BB/F003811/1] Funding Source: researchfish
  9. National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) [NC/K001280/1] Funding Source: researchfish
  10. BBSRC [BB/G023395/1, BB/F003811/1] Funding Source: UKRI

向作者/读者索取更多资源

Highly functional CD8(+) effector T (Teff) cells can persist in large numbers during controlled persistent infections, as exemplified by rare HIV-infected individuals who control the virus. Here we examined the cellular mechanisms that maintain ongoing T effector responses using a mouse model for persistent Toxoplasma gondii infection. In mice expressing the protective MHC-I molecule, H-2L(d), a dominant T effector response against a single parasite antigen was maintained without a contraction phase, correlating with ongoing presentation of the dominant antigen. Large numbers of short-lived Teff cells were continuously produced via a proliferative, antigen-dependent intermediate (Tint) population with a memory-effector hybrid phenotype. During an acute, resolved infection, decreasing antigen load correlated with a sharp drop in the Tint cell population and subsequent loss of the ongoing effector response. Vaccination approaches aimed at the development of Tint populations might prove effective against pathogens that lead to chronic infection.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据